Your browser doesn't support javascript.
loading
HLA specificities are associated with prognosis in IGHV-mutated CLL-like high-count monoclonal B cell lymphocytosis.
García-Álvarez, María; Alcoceba, Miguel; López-Parra, Miriam; Puig, Noemí; Antón, Alicia; Balanzategui, Ana; Prieto-Conde, Isabel; Jiménez, Cristina; Sarasquete, María E; Chillón, M Carmen; Gutiérrez, María Laura; Corral, Rocío; Alonso, José María; Queizán, José Antonio; Vidán, Julia; Pardal, Emilia; Peñarrubia, María Jesús; Bastida, José M; García-Sanz, Ramón; Marín, Luis; González, Marcos.
Afiliación
  • García-Álvarez M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Alcoceba M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • López-Parra M; Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain.
  • Puig N; CIBERONC, Madrid, Spain.
  • Antón A; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Balanzategui A; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Prieto-Conde I; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Jiménez C; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Sarasquete ME; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Chillón MC; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Gutiérrez ML; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Corral R; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Alonso JM; CIBERONC, Madrid, Spain.
  • Queizán JA; Cytometry Service-NUCLEUS, Department of Medicine, Cancer Research Center (IBMCC-CSIC/USAL) and IBSAL (University of Salamanca), Salamanca, Spain.
  • Vidán J; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
  • Pardal E; Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain.
  • Peñarrubia MJ; Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain.
  • Bastida JM; Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain.
  • García-Sanz R; Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain.
  • Marín L; Cooperative Working Group on Lymphomas and Lymphoproliferative Disorders of the Castilla y León Society of Hematology and Hemotherapy (SCLHH), Castilla y León, Spain.
  • González M; Department of Hematology, University Hospital of Salamanca (HUS-IBSAL), Salamanca, Spain.
PLoS One ; 12(3): e0172978, 2017.
Article en En | MEDLINE | ID: mdl-28249016
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Genes de las Cadenas Pesadas de las Inmunoglobulinas / Linfocitosis / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Genes de las Cadenas Pesadas de las Inmunoglobulinas / Linfocitosis / Mutación Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos